FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression

The FDA is helping to speed up the process of developing and approving a drug based on psilocybin, a hallucinogenic substance in magic mushrooms, to treat depression.

The post FDA Calls Psychedelic Psilocybin a ‘Breakthrough Therapy’ for Severe Depression appeared first on Scout SEO- Melbourne Internet Marketing.

from Innovation and Digital Marketing https://www.livescience.com/psilocybin-depression-breakthrough-therapy.html?utm_source=rss&utm_medium=rss